Mar 01, 2023 / 07:45PM GMT
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior Analyst
We'll get started. Thanks, everyone, for joining us. I'm Patrick Donnelly, Tools and Diagnostics analyst here at Citi. Happy to have Jeff Elliott, the CFO, COO of Exact Sciences with us. A lot to go through, obviously, with you guys.
Questions and Answers:
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior AnalystMaybe we can start off just on -- just chatting about it, just on the 4Q kind of number and then that progression into 1Q. I know there were some revenue recognition in the 4Q piece in terms of some catch-up.
So maybe talk through the 4Q results, obviously really strong, kind of what inflected there. And then again, maybe -- say onetime, but maybe some benefits there that kind of won't quite recur.
Jeffrey T. Elliott - Exact Sciences Corporation - Executive VP, CFO & COO
Sure. Thanks, Patrick. Thanks, everyone in the room, and thanks Citi for having us. Great to be back here in person. So we